Hensoldt's Ordeal: Record Orders of €9.8 Billion, Yet Shares Sink 31% From October Peak

Defence contractor Hensoldt's shares tumble even as backlog hits €9.8B and cash flow guidance raised, caught between technical resistance, China export controls, and sector-wide sell-off.

For a defence contractor with an all-time-high order book and a cash-flow forecast that just got upgraded, the share price ought to be celebrating. At Hensoldt, the opposite is happening. The stock has tumbled 31 percent from its October 2025 peak and now trades at €78.32, wedged below its 50-, 100- and 200-day moving averages. The disconnect between operational strength and market sentiment has rarely been this stark.

Behind the share-price gloom lies a business firing on all operational cylinders. In the first quarter, order intake nearly doubled to roughly €1.5 billion, pushing the total backlog to a record €9.8 billion — equivalent to 3.5 times the €2.75 billion in revenue Hensoldt expects for 2026. Management recently raised its adjusted free cash flow guidance to around 50 percent of adjusted EBITDA, up from 40 percent, propelled by higher customer advance payments as Germany accelerates its procurement cycles. Technology additions include the completed acquisition of Nedinsco to strengthen optronics for armoured vehicles, and the launch of OrbitISR, a modular SAR radar for satellite-based reconnaissance that analysts link to the Bundeswehr's SPOCK 2 programme.

Yet the technical picture tells a different story. The three key moving averages form a layered resistance zone between €79 and €84. The 50-day simple moving average sits at €78.85 — barely 0.67 percent above the current price — while the 100-day SMA is at €79.87 and the 200-day SMA at €83.54. On a separate reading, the 50-day average has been calculated at €78.72 and the 200-day at €83.60, underscoring the tight range. The relative strength index (14-day) hovers around 45.0 to 45.6, neutral territory that offers no technical trigger. The stock has lost 10.9 percent in the past seven days and is down 27 percent year-on-year, though it still shows a 2.51 percent gain on a year-to-date basis. The 200-day line at €83.54 is the key threshold for a reversal; until the stock closes sustainably above that level, the downtrend that began in October remains intact.

Three distinct headwinds are weighing on the stock. First, China placed Hensoldt on an export control list. The company sees no material impact on operating results, but the risk remains for rare earths and dual-use components, given China controls about 90 percent of global rare-earth processing. Second, a sector-wide sell-off has swept across European defence names: Rheinmetall fell 6.68 percent, Renk lost 7.85 percent and TKMS dropped 6.05 percent. Hensoldt is being dragged down by a tide that pays little attention to individual fundamentals. Third, a chronic production bottleneck means orders are coming in at nearly double the rate Hensoldt can execute. The company plans to add 1,600 new jobs by 2026 and invest roughly €1 billion in German production capacity between 2025 and 2027 — but the lag between booking and delivery is a persistent drag on investor confidence. Looking ahead, the market expects KNDS to launch its initial public offering in June 2026 at a valuation of €15 billion to €20 billion, which could prompt defence-sector funds to shift liquidity toward the new name at the expense of existing holdings like Hensoldt.

Analysts remain cautiously optimistic. Jefferies maintains a "Buy" rating with a €90 price target, while Barclays lifted its target from €95 to €97 but rates the stock "Equal Weight", noting that the cash flow upgrade was expected and merely confirms conservative planning. With annualised 30-day volatility at 52.61 percent, Hensoldt behaves like a politically charged technology stock, vulnerable to rotations and valuation doubts. The 52-week low of €64.80 provides a support floor 20.86 percent below the current level — a buffer that could absorb short-term selling but is thin in a high-volatility environment.

The stock's next real test comes with half-year results in July, when investors will look for evidence that production is finally catching up with the order intake. Until then, Hensoldt remains a story of operational excellence clashing with technical deterioration — a paradox that no amount of record backlog can single-handedly resolve.